| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/09/2005 | CN1192102C Enzyme catalyzed therapeutic agents |
| 03/09/2005 | CN1192097C Multi-array, multi-specific electrochemiluminescence testing |
| 03/09/2005 | CN1192037C Signal sequence for production of leu-hirudine via secretion by E coli in culture medium |
| 03/08/2005 | US6865491 Method for sequencing polynucleotides |
| 03/08/2005 | US6864364 MinK-related genes, formation of potassium channels and association with cardiac arrhythmia |
| 03/08/2005 | US6864358 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 03/08/2005 | US6864227 Artery-and vein-specific proteins and uses therefor |
| 03/08/2005 | US6864224 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth |
| 03/08/2005 | US6864103 Such as hydroxyisophthamidylamide-based bidentate ligands; bioavailiable probes for use in immunoassay |
| 03/08/2005 | US6864102 Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device |
| 03/08/2005 | US6864100 Automated protein purification the multiwell format by vacuum filtration |
| 03/08/2005 | US6864099 Attaching first and second isotopic variants of chemical moiety to protein in first and second samples, subjecting mixture to mass spectrometric analysis to determine difference in concentration in samples |
| 03/08/2005 | US6864097 Arrays and their reading |
| 03/08/2005 | US6864093 Method of identifying and treating invasive carcinomas |
| 03/08/2005 | US6864076 Protein for use in the prevention of fungal infection |
| 03/08/2005 | US6864073 Avermectin aglycon synthase genes |
| 03/08/2005 | US6864071 Accumulation of preferential nucleotide sequences; obtain nucleotide sequences, incubate with probes and primers, ligate terminals, propagate amplicons and recover sequences |
| 03/08/2005 | US6864070 Polypeptide for use in the treatment of vision defects and psychological disorders |
| 03/08/2005 | US6864067 Compositions and methods for regulating bacterial pathogenesis |
| 03/08/2005 | US6864064 18891, a novel human lipase |
| 03/08/2005 | US6864061 Detecting modulators of anti-inflammatory activity; obtain cells, incubate with modulator, monitor adjustment in inflammatory activity |
| 03/08/2005 | US6864059 Coupling a nucleic acid labeling compound (a biotin compound attached to a nucleic acid base derivative containing triphosphate) with a nucleic acid |
| 03/08/2005 | US6864058 Vaccinia topoisomerases I-based assays for detection of specific DNA breaks |
| 03/08/2005 | US6864056 Method for detecting ribosome inactivating proteins |
| 03/08/2005 | US6864055 Method for detecting nucleic acids |
| 03/08/2005 | US6864053 Quantitative assay of host cell DNA in a sample |
| 03/08/2005 | US6864052 Enhanced sequencing by hybridization using pools of probes |
| 03/08/2005 | US6864050 Single-phase amplification of nucleic acids |
| 03/08/2005 | US6864049 Consists contacting a first nucleic acid molecule with a second nucleic acid molecule under conditions enabling the formation of a specific hybridization complex |
| 03/08/2005 | US6863892 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer |
| 03/08/2005 | US6863880 Methods to diagnose a required regulation of trophoblast invasion |
| 03/08/2005 | US6863801 Biosensor such as for determining glucose concentration in blood |
| 03/08/2005 | US6863800 Determination glucose concentration in blood |
| 03/08/2005 | US6863196 Apparatus for hanging hats |
| 03/08/2005 | CA2262776C Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 03/03/2005 | WO2005020125A2 Methods and systems for profiling biological systems |
| 03/03/2005 | WO2005019832A2 Quantification and site-specific profiling of protein phosphorylation |
| 03/03/2005 | WO2005019831A2 Methods for reducing complexity of a sample using small epitope antibodies |
| 03/03/2005 | WO2005019829A1 Inhibition of s6 kinase activity for the treatment of insulin resistance |
| 03/03/2005 | WO2005019801A2 Method for rapid identification of molecules with functional activity towards biomolecular targets |
| 03/03/2005 | WO2005019795A2 Electrochemical sensors including electrode systems with increased oxygen generation |
| 03/03/2005 | WO2005019479A1 A quantification method for integrated viruses |
| 03/03/2005 | WO2005019478A1 Methods and compositions for modulating herpesviral replication and transcription activator |
| 03/03/2005 | WO2005019477A2 Methods and compositions for differentiating tissues or cell types using epigenetic markers |
| 03/03/2005 | WO2005019476A1 Polymerase compositions |
| 03/03/2005 | WO2005019475A2 Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc) |
| 03/03/2005 | WO2005019474A2 Human autism susceptibility gene and uses thereof |
| 03/03/2005 | WO2005019473A2 Use of silver gene for the authentication of the racial origin of animal populations, and of the derivative products thereof |
| 03/03/2005 | WO2005019472A1 Method of detecting effect of controlling synoviolin activity |
| 03/03/2005 | WO2005019469A2 Rna detection and quantitation |
| 03/03/2005 | WO2005019457A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 03/03/2005 | WO2005019447A1 Monochromatic fluorescent probe |
| 03/03/2005 | WO2005019433A2 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi |
| 03/03/2005 | WO2005019430A2 In vitro selection of aptamer beacons |
| 03/03/2005 | WO2005019427A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 03/03/2005 | WO2005019426A2 Gene cluster for fostriecin biosynthesis |
| 03/03/2005 | WO2005019423A2 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 03/03/2005 | WO2005019419A2 Co-detection of single polypeptide and polynucleotide molecules |
| 03/03/2005 | WO2005019413A2 A low maintenance detector for biological agents |
| 03/03/2005 | WO2005019410A2 Rnai agents for anti-sars coronavirus therapy |
| 03/03/2005 | WO2005019409A2 Combinatorial protein library screening by periplasmic expression |
| 03/03/2005 | WO2005019268A1 Novel antibody against cancer antigen |
| 03/03/2005 | WO2005019259A2 Variants of interleukin-1 receptor antagonist: compositions and uses thereof |
| 03/03/2005 | WO2005019251A2 Novel fungal proteins and nucleic acids encoding same |
| 03/03/2005 | WO2005019249A2 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2005 | WO2005019248A1 Hiv immunogenic complexes |
| 03/03/2005 | WO2005019235A2 Use of novel compounds to release nucleotides from living cells |
| 03/03/2005 | WO2005019136A2 Methods and compositions for degradation of nitroaromatic and nitramine pollutants |
| 03/03/2005 | WO2005018673A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |
| 03/03/2005 | WO2005018436A2 Methods for the diagnosis, prognosis and treatment of metabolic syndrome |
| 03/03/2005 | WO2005018431A2 Compositions and methods for detecting and treating neurological conditions |
| 03/03/2005 | WO2005018423A2 Pna oligomers, oligomer sets, methods and kits pertaining to the determination of enterococcus faecalis and other enterococcus species |
| 03/03/2005 | WO2005018414A2 Detection of somatic cells in milk |
| 03/03/2005 | WO2005005977A3 Fluorescent phospholipase assays and compositions |
| 03/03/2005 | WO2005005652A3 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants |
| 03/03/2005 | WO2005000088A3 Expression profile of pancreatic cancer |
| 03/03/2005 | WO2004106891A3 Ultrasensitive biochemical sensor |
| 03/03/2005 | WO2004106554A3 Primase dna templates |
| 03/03/2005 | WO2004106536A3 Diagnostics and therapeutics for diseases associated with serine protease 8 (prss8) |
| 03/03/2005 | WO2004104216A3 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| 03/03/2005 | WO2004104211A3 Method for detecting toxic and non-toxic cyanobacteria |
| 03/03/2005 | WO2004098647A3 Claudins’ underexpression as markers of tumor metastasis |
| 03/03/2005 | WO2004094668A3 Oligonucleotide pairs for multiplexed binding assays |
| 03/03/2005 | WO2004094667A3 Reagents and methods for detecting severe acute respiratory syndrome coronavirus |
| 03/03/2005 | WO2004092412A3 Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup |
| 03/03/2005 | WO2004092408A3 Oligonucleotides for the detection of salmonella species |
| 03/03/2005 | WO2004092404A3 Inhibitors of acidic mammalian chitinase as asthma therapeutics |
| 03/03/2005 | WO2004092325A3 Screening methods using zebrafish to identify thrombotic and anti-thrombotic compounds and genes |
| 03/03/2005 | WO2004091476A3 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 03/03/2005 | WO2004090104A3 Detecting gene expression in live cells using short-lived reporters with enzymatic amplification |
| 03/03/2005 | WO2004085480A3 Process and composition for assaying carbohydrates |
| 03/03/2005 | WO2004081563A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a) |
| 03/03/2005 | WO2004075835A3 Methods for the treatment of renal cell carcinoma |
| 03/03/2005 | WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using |
| 03/03/2005 | WO2004072265A3 Methods for monitoring drug activities in vivo |
| 03/03/2005 | WO2004065583A3 Gene expression markers for breast cancer prognosis |
| 03/03/2005 | WO2004063962A3 Linkage analysis using direct and indirect counting |
| 03/03/2005 | WO2004059001A3 Method for determining markers of human facial skin |